Search Results
What Is the Impact of the Talquetamab Accelerated Approval in Multiple Myeloma?
What is the monoclonal antibody TALVEY™ (talquetamab)?
All About TALVEY (talquetamab)
Dr. Chari Discusses How He Manages Side Effects Related to Talquetamab
What should myeloma patients know about talquetamab?
ASH 2022: Talquetamab Showing Promise in Multiple Myeloma Clinical Trial
FDA D.I.S.C.O. Burst Edition: FDA approvals of Talvey (talquetamab-tgvs) for relapsed or refracto...
Myeloma Panel Discusses 3 FDA-Approved Bispecific Agents: Talquetamab, Teclistamab, Elranatamab
MonumenTAL-1: talquetamab in R/R multiple myeloma
Talquetamab Side Effect Management
Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma
Talquetamab | Ajai Chari, MD | ASH 2022
